MedTrace Logo

Asian-Mediterranean Diet and Women's Health

NCT06825936 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 300

Last updated 2025-03-12

No results posted yet for this study

Summary

Given the escalating high burdens of overeight and obesity, and related commobidies in Asia, Asian women with overweight/obesity is an important group for targeted intervention in promoting health and wellbeing. A study focused on Asian women at reproductive or early post-menopausal age can inform effective strategies for promoting healthy diet and lifetyle and for optimizing health not only among these women but also for their children and partners.

The Mediterranean diet has beneficial effects on cardiometabolic and reproductive health. So far, evidence on the Mediterranean diet and its health benefits mostly come from Western populations. Studies evaluating health effects of Mediterranean diet in Asian population are scant.

This study aims to investigate the beneficial effects of a healthy, Mediterranean-inspired localized diet (i.e., Asian-Mediterranean diet) on women's health, such as cardiometabolic health with potential mechanisms through modulating gut and brain health.

Conditions

  • Cardiometabolic Risk Factors
  • Cardiometabolic Conditions
  • Women Health

Interventions

OTHER

Diet intervention

For participants assigned to the intervention arm, the dietary intervention consists of: a) pre-cooked Asian-Mediterranean meals: participants will receive free meals, two meals a day, five days a week, and b) pre-packed nuts, 30g a day, five days a week, during the intervention period. Additionally, participants will receive a dietary consultation session at baseline and every four weeks.

OTHER

Control

For participants assigned to the control arm, they will receive a leaflet with dietary advice based on national guidelines at baseline.

Sponsors & Collaborators

  • Yong Loo Lin School of Medicine

    collaborator OTHER

  • Global Centre for Asian Women's Health

    lead OTHER

Principal Investigators

  • Cuilin Zhang, MD, MPH, PhD · Global Centre for Asian Women's Health, Yong Loo Lin School of Medicine, National University of Singapore

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
21 Years
Max Age
50 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2025-02-10
Primary Completion
2026-07-31
Completion
2026-10-31

Countries

  • Singapore

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06825936 on ClinicalTrials.gov